Ascension reported operating revenues of $12.6 billion for the six months ended Dec. 31, up $1.3 billion from $11.3 billion reported in the first six months of fiscal 2018, according to unaudited financial documents. The increase was primarily attributed to revenue recorded by Chicago-based Presence Health facilities, which Ascension acquired in March 2018.
Ascension also saw operating expenses increase in the first half of fiscal 2019 to $12.3 billion, up 10.3 percent from $11.2 billion reported in the same period a year prior. The increase in operating expenses was primarily due to the Presence acquisition.
The health system saw its operating income improve in the first half of 2019 to $221.8 million, up 162 percent from $84.7 million reported in the first half of the previous fiscal year. Net impairment, restructuring and nonrecurring losses were $42.4 million for the most recent six-month period, down from losses of $78.3 million during the six months ended Dec. 31, 2017.
However, largely due to lower return on investment, Ascension posted an $836.3 million nonoperating loss in the first half of fiscal 2019, compared to a nonoperating gain of $923.2 million in the same period a year prior. After including the nonoperating loss, Ascension reported a net loss of $567.9 million in the first half of 2019, compared to a net gain of $882.2 million in the first half of fiscal 2018.
More articles on healthcare finance:
Ohio hospital to close after 105 years
Alabama hospital to close in March
Kansas hospital abruptly closes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
